Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of AER 001 in atopic asthmatic subjects with antigen challenge
2004-002836-25Phase 2Completed
- Sponsor
- Aerovance
- Start
- Feb 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of pitrakinra in asthma, sponsored by Aerovance. Primary endpoint: Late asthmatic response to antigen challenge. Started Feb 2005; status: completed.
02
Drugs
pitrakinra
03
Conditions
asthma
Beyond the preview
Go deeper on 2004-002836-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002836-25.